Navigation Links
Advanced Tissue Services Offering Discounts on Bio-specimens Utilized in Academic Research
Date:8/15/2013

Tucson, Arizona (PRWEB) August 15, 2013

Advanced Tissue Services is offering a discount to academic institutions in need of human tissue and bio-specimens. The company is asking interested universities to contact the company. The company will provide an Academic ID upon enrollment.

The human tissue company is charting a move to the University of Arizona’s Bio5 Institute located in Oro Valley. BIO 5 is home to the University of Arizona’s translational drug discovery and development center. Located just north of Tucson, Ariz., nestled in the foothills of the Santa Catalina mountains, Oro Valley has emerged as a bio-industry hub. Multiple drug companies have moved to several research parks in the area.

The human tissue company provides specimens in both normal and/or diseased states. Sample types include: cell lines, formalin fixed paraffin embedded (FFPE) tissue, frozen tissue and fresh tissue. The company only obtains bio-specimens from network sources who have provided documented assurances of their appropriate IRB/ethics committee, licensing, or like entity, approvals.

About Advanced Tissue Services (ATS) - Advanced Tissue Services (ATS) provides high quality and well-characterized human biological specimens for utilization in research and development in clinical, basic science, translational, biotechnology and pharmaceutical practices. The clients receive personalized attention from the ATS professionals to maximize the understanding of client research development goals.

About Nuanced Media - Nuanced Media is a digital marketing and graphic design firm. The company specializes in strategic, multilayer marketing campaigns and efficiently crafted, user-friendly websites. Based in Tucson, the company has a variety of clients throughout Arizona, California, and Texas. For more information, please view Nuanced Media.

Read the full story at http://www.prweb.com/releases/human-tissue/human-tissue/prweb11025403.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
2. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
3. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
4. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
5. CareFusion Announces 510(k) Clearance and U.S. Launch of New Advanced Electrodiagnostic System
6. QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to Worlds Poorest Countries
7. Algae.Tec Announces Commencement of Australian Advanced Biofuels Facility Commissioning
8. Bayer Advanced(TM) Sets Sights on New Partnerships in 2013
9. Advanced Animal Diagnostics Adds Sales & Marketing Leadership
10. MAQUET MEDICAL SYSTEMS USA LAUNCHES NEW TEGRIS O.R. INTEGRATION SYSTEM FOR ADVANCED SURGICAL CONTROL
11. Gevo Doesnt Infringe Butamaxs 017 Patent; Gevo was First to Invent Enzyme in 017 Patent; Gevo has Advanced Beyond That and Now Uses Different Enzymes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... and GREENWICH, Conn. , Feb. ... firm focused on venture growth investments in biotechnology ... Josh Richardson , M.D. to Managing Director. ... biotechnology companies.  He is a board observer at ... in Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, ...
(Date:2/16/2017)... CALABASAS, Calif. , Feb. 16, 2017 /PRNewswire/ ... on developing groundbreaking therapies to treat severe neurological ... in children treated with AGT-181, the company,s investigational ... syndrome (also known as mucopolysaccharidosis type I, or ... Phase 2 proof-of-concept (POC) study, presented today at ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , February 16, 2017 ... infusion of innovative telemedicine application, new and leading ... are experiencing a boom worldwide. The healthcare sector ... of technologies, services and new therapies for companies ... (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):